Atomera Inc

Atomera Incorporated (NASDAQ: ATOM) is a semiconductor technology company that develops, commercializes, and licenses proprietary processes and technologies to the semiconductor industry. The company's website is www.atomera.com.

The company's lead technology, Mears Silicon Technology or MST, is a thin film of reengineered silicon designed to enhance semiconductor performance. MST enables transistors to be made smaller with increased speed, reliability, and power efficiency while maintaining compatibility with existing manufacturing equipment and processes. The technology addresses key engineering challenges in the semiconductor industry by enhancing drive current, reducing leakage, and reducing variability in semiconductor devices. MST can be applied across multiple semiconductor product types, including analog, logic, optical, and memory integrated circuits, as well as power devices, RF devices, and compound semiconductors such as gallium nitride devices.

Rather than designing or manufacturing semiconductors directly, Atomera operates a licensing business model. The company generates revenue through upfront license fees and ongoing royalties from customers who incorporate MST into their manufacturing processes. Customers and partners include semiconductor foundries, integrated device manufacturers, fabless semiconductor manufacturers, wafer manufacturers, epitaxial equipment manufacturers, and electronic design automation software companies. The company also licenses MSTcad software, which enables customers to simulate MST integration using industry-standard TCAD software, and provides fee-based engineering services through evaluation arrangements and joint development agreements.

Atomera maintains strategic partnerships with leading industry players, including a long-standing collaboration with Synopsys on TCAD simulation capabilities and a 2025 strategic marketing agreement with a major chip fabrication equipment vendor focused on next-generation logic and memory technologies. The company operates leased epitaxial deposition tools in Arizona for internal research and development and customer evaluation activities.

As of the filing date, Atomera employs 21 full-time employees. The company has built a substantial intellectual property portfolio with 119 granted U.S. patents and 130 foreign patents, along with 75 pending U.S. applications and 106 pending foreign applications. The company holds registered trademarks for Atomera, MST, and MSTcad.